Prebiotics with Special Emphasis on Fructo-, Galacto-, Galacturono-, and Xylooligosaccharides

Comprehensive Glycoscience: From Chemistry to Systems Biology

Volumn 4-4, Issue , 2007, Pages 725-742

  Stahl, B ^a   Zens, Y ^a   Boehm, G ^a  

^a Numico Research Germany   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85031041194     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044451967-2/00154-9     Document Type: Chapter

References (164)

1. Dai D., Nanthkumar N.N., Newburg D.S., Walker W.A. Role of oligosaccharides and glycoconjugates in intestinal host defense. JPGN 2000, 30:23-33.
2. Gornik O., Dumic J., Flögel M., Lauc G. Glycoscience - a new frontier in rational drug design. Acta Pharm. 2006, 56:19-30.
3. Varki A. Nothing in glycobiology makes sense, except in the light of evolution. Cell 2006, 126:841-845.
4. Holzer C.T., von Itzstein M., Jin B., Pegg M.S., Stewart W.P., Wu W.Y. Inhibition of sialidases from viral, bacterial and mammalian sources by analogues of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid modified at the C4 position. Glycoconj. J 1993, 10:40-44.
5. von Itzstein M., Wu W.Y., Kok G.B., Pegg M.S., Dyason J.C., Jin B., Van Phan T., Smythe M.L., White H.F., Oliver S.W. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993, 363:418-423.
6. Varki A., Angata T. Siglecs - the major subfamily of I-type lectins. Glycobiology 2006, 16:1-27.
7. Petitou M., Casu B., Lindahl U. 1976-1983, a critical period in the history of heparin: The discovery of the antithrombin binding site. Biochimie 2003, 85:83-89.
8. Bavenholm P.N., Efendic S. Postprandial hyperglycaemia and vascular damage - the benefits of acarbose. Diabetes Vasc. Dis. Res. 2006, 3:72-79.
9. Vliegenthart J.F.G. Carbohydrate-based vaccines. FEBS Lett. 2006, 580:2945-2950.
10. Wang L.X. Toward oligosaccharide- and glycopeptide-based HIV vaccines. Curr. Opin. Drug Dis. Dev. 2006, 9:194-206.
11. Romano S.J. Selectin antagonists. Therapeutic potential in asthma and COPD. Treat. Respir. Med. 2005, 4:85-94.
12. Holgersson J., Gustafsson A., Breimer M.E. Characteristics of protein-carbohydrate interactions as a basis for developing novel carbohydrate-based antirejection therapies. Immunol. Cell Biol. 2005, 83:694-708.
13. Holtmann M. Beeinflusst die Ernährungstherapie das immunsystem der intestinalen mukosa?. Aktuelle Ernährungsmedizin 2005, 30:136-141.
14. Schrezenmeir J., DeVrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am. J. Clin. Nutr. 2001, 73:361-364.
15. Leahy S.C., Higgins D.G., Fitzgerald G.F., VanSindersen D. Getting better with bifidobacteria. J. Appl. Microbiol. 2005, 98:1303-1315.
16. Foulquie-Morenoa M.R., Sarantinopoulos P., Tsakalidou E., De Vuyst L. The role and application of enterococci in food and health. Int. J. Food Microbiol. 2006, 106:1-24.
17. Roberfroid M.B. Chicory fructooligosaccharides and the gastrointestinal tract. Nutrition 2000, 16:677-679.
18. Roberfroid M.B. Prebiotics and probiotics: Are they functional foods?. Am. J. Clin. Nutr. 2000, 71:1682-1687.
19. Escherich T. The intestinal bacteria of the neonate and breast fed infants, 1885. Rev. Infect. Dis. 1989, 11:352-356.
20. Tuohy K.M., Kolida S., Lustenberger A.M., Gibson G.R. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides - a human volunteer study. Br. J. Nutr. 2001, 86:341-348.
21. VanLoo J. Prebiotics promote good health. The basis, the potential, and the emerging evidence. J. Clin. Gastroenterol. 2004, 38:70-75.
22. Biedrzycka E., Bielecka M. Prebiotic effectiveness of fructans of different degree of polymerization. Trends Food Sci. Technol. 2004, 15:170-175.
23. Gibson G.R. Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr. Res. Rev. 2004, 17:259-275.
24. Moro G., Minoli I., Mosca M., Fanaro S., Jelinek J., Stahl B., Boehm G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. JPGN 2002, 34:291-295.
25. Abbreviated terminology of oligosaccharide chains. Recommendations. J. Biol. Chem. 1980, 257:334. IUB-IUPAC Joint Commission on Biochemical Nomenclature, 1980.
26. Chapman and Hall. British Nutrition Foundation complex carbohydrates in foods. Report of the British Nutrition's Task Force. London, 1990.
27. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annu. Rev. Nutr. 2000, 20:699-722.
28. Nomenclature of carbohydrates. Recommendations. Carbohydr. Res. 1997, 297:9. IUPAC/IUBMB Joint Commission on Biochemical Nomenclature.
29. György P., Norris R.F., Rose C.S. A variant of Lactobacillus bifidus requiring a special growth factor. Arch. Biochem. Biophys. 1954, 48:193-201.
30. Tissier H.C.R. La vécation chromophile d'Escherich et la Bacterium coli. Soc. Biol. 1899, 51:943-945.
31. Moro E. Karottensuppe bei Ernährungsstörungen der Säuglinge. Münchener Medizinische Wochenzeitschrift 1908, 31:1637-1640.
32. Fanaro S., Boehm G., Garssen J., Knol J., Mosca F., Stahl B., Vigi V. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: A review. Acta Paediatr. 2005, 94:22-26.
33. Thurl S., Müller-Werner B., Sawatzki G. Quantification of individual oligosaccharide compounds from human milk by gel chromatography. Anal Biochem. 1996, 235:202-206.
34. Kunz C., Rudloff S., Baier W., Klein N., Strobel S. Oligosaccharides in human milk: Structural, functional, and metabolic aspects. Annu. Rev. Nutr. 2000, 20:699-722.
35. Beachy E.H. Bacterial adherence: Adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface. J. Infect. Dis. 1981, 143:325-345.
36. Coppa G.V., Gabrielli O., Giorgi P., Catassi C., Montanari M.P., Varaldo P.E., Nichols B.L. Preliminary study of breastfeeding and bacterial adhesion to uroepithelial cells. Lancet 1990, 335:569-571.
37. Newburg D.S. Human milk oligosaccharides that inhibit pathogens. Curr. Med. Chem. 1999, 6:117-127.
38. Zopf D., Roth S. Oligosaccharide anti-infective agents. Lancet 1996, 347:1017-1021.
39. Urashima T., Murata S., Nakamura T. Structural determination of monosialyl trisaccharides obtained from caprine colostrum. Comp. Biochem. Physiol. 1997, 116:431-435.
40. Mouricout M., Petit J.M., Carias J.R., Julien R. Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: Treatment of experimental colibacillosis. Infect. Immun. 1990, 58:98-106.
41. Coppa G.V., Pierani L., Zampini L., Bruni S., Carloni I., Gabrielli O. Characterization of oligosaccharides in milk and feces by high-performance anion exchange chromatography. Bioactive Components of Human Milk 2001, 307-313. Kluwer Academic/Plenum Publisher, New York. D.S. Newburg (Ed.).
42. Rivero-Urgell M., Santamaria-Orleans A. Oligosaccharides: Application in infant food. Early Hum. Dev. 2001, 65:43-52.
43. Engfer M.B., Stahl B., Finke B., Sawatzki G., Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am. J. Clin. Nutr. 2000, 71:1589-1596.
44. Gnoth M.J., Kunz C., Kinne-Saffran E., Rudloff S. Human milk oligosaccharides are minimally digested in vitro. J. Nutr. 2000, 130:3014-3020.
45. Roberfroid M.B., Delzenne N.M. Dietary fructans. Annu. Rev. Nutr. 1998, 18:117-143.
46. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995, 125:1401-1412.
47. Loo J.V., Cummings J.H., Delzenne N.M., Englyst H., Frank A., Hopkins M., Kok N., Macfarlane G., Newton D., Quingley M., Roberfroid M.B., Vliet T., Heuvel E. Functional food properties on non-digestible oligosaccharides: A consensus report from the ENDO project (DGXII AIRII-CT94-1095). Br. J. Nutr. 1999, 81:121-132.
48. Jenkins D.J., Kendall C.W.C., Vuksan V. Inulin, oligofructose and intestinal function. J. Nutr. 1999, 129:1431-1433.
49. Gibson G.R. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J. Nutr. 1999, 125:1438-1441.
50. Miniello V.L., Moro G., Armenio L. Prebiotics in infant milk formulas: New perspectives. Acta Paediatr. 2003, 91:68-76.
51. Carabin I.G., Flamm W.G. Evaluation of safety of inulin and oligofructose as dietary fiber. Toxicol. Pharmacol. 1999, 30:268-282.
52. Boehm G., Fanaro S., Jelinek J., Stahl B., Marini A. Prebiotic concept for infant nutrition. Acta Paediatr. 2003, 91:64-67.
53. Roberfroid M.B. Introducing inulin-type fructans. Br. J. Nutr. 2005, 93:13-25.
54. Frank A. Inulin. Polysaccharides and Polyamides in the Food Industry 2005, 281-322. Wiley, Weinheim, Germany. 2nd ed. A. Steinbüchel, S. Ki Rhee (Eds.).
55. Roberfroid M.B. Health benefits of non-digestible oligosaccharides. Adv. Exp. Biol. 1997, 427:211-219.
56. Naughton P.J., Mikkelsen L.L., Jensen B.B. Effects on non-digestible oligosaccharides on Salmonella enterica serovar Typhimurium and non-pathogenic Escherichia coli in pig small intestine in vitro. Appl. Environ. Microbiol. 2001, 67:3391-3395.
57. Gibson G.R., McCartney A.L., Rastell R.A. Prebiotics and resistance to gastrointestinal infections. Br. J. Nutr. 2005, 1:31-34.
58. Vijaya Kumar S.G., Singh S.K., Goyal P., Dilbaghi N., Mishra D.N. Beneficial effects of probiotics and prebiotics on human health. Pharmazie 2005, 60:163-171.
59. Fujiwara S., Hashiba H., Hirota T., Forstner J.F. Proteinaceous factor(s) in culture supernatant fluids of bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl. Environ. Microbiol. 1997, 63:506-512.
60. Picard C., Fioramonti J., Francois A., Robinson T., Neant F., Matuchansky C. Review article: Bifidobacteria as probiotic agents - physiological effects and clinical benefits. Aliment Pharmacol. Ther. 2005, 22:495-512.
61. Buddington K.K., Donahoo J.B., Buddington R.K. Dietary oligofructose and inulin protect mice from enteric and systemic pathogens and tumor inducers. J. Nutr. 2002, 132:472-477.
62. Kleessen B., Hartmann L., Blaut M. Fructans in the diet cause alterations of intestinal mucosal architecture, released mucins and mucosa-associated bifidobacteria in gnotobiotic rats. Br. J. Nutr. 2003, 89:597-606.
63. Kleessen B., Blaut M. Modulation of gut mucosal biofilms. Br. J. Nutr. 2005, 93:35-40.
64. Whelan K., Judd P.A., Preedy V.R., Simmering R., Jann A., Taylor M.A. Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and short-chain fatty acid concentrations caused by standard enteral formula in healthy humans. J. Nutr. 2005, 135:1896-1902.
65. Hoekstra J.H., Szajewska H., Zikri M.A., Micetic-Turk D., Wiezman Z., Papadopoulou A., Guarino A., Dias J.A., Oostvogels B. Oral rehydration solution containing a mixture of non-digestible carbohydrates in the treatment of acute diarrhea: A mulitcenter randomized placebo controlled study on behalf of the ESPGHAN working group in intestinal infections. JPGN 2004, 39:239-245.
66. Bunout D., Hirsch S., De La Maza M.P., Munoz C., Haschke F., Steenhout P., Klassen P., Barrera G., Gattas V., Petermann M. Effects of prebiotics on the immune response to vaccination in the elderly. JPEN 2002, 26:372-376.
67. Nakamura Y., Nosaka S., Suzuki M., Nagafuchi S., Takahashi T., Yajima T., Takenouchi-Ohkubo N., Iwase T., Moro I. Dietary fructooligosaccharides up-regulate immunoglobulin A response and polymeric immunoglobulin receptor expression in intestines of infant mice. Clin. Exp. Immunol. 2004, 137:52-58.
68. Hosono A., Ozawa A., Kato R., Ohnishi Y., Nakanishi Y., Kimura T., Nakamura R. Dietary fructooligosaccharides induce immunoregulation of intestinal IgA secretion by murine Peyer's patch cells. Biosci. Biotechnol. Biochem. 2003, 67:758-764.
69. Cherbut C., Michel C., Lecannu G. The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J. Nutr. 2003, 133:21-27.
70. Guarner F. Inulin and oligofructose: Impact on intestinal diseases and disorders. Br. J. Nutr. 2005, 93:61-65.
71. Tanaka R., Matsumoto K. Recent progress on prebiotics in Japan, including galactooligosaccharides. Bull. IDF 1998, 336:21-27.
72. Commercial use of β-galactosidase in food processing. Advances in Food and Nutrition Research 1995, Academic Press, San Diego, CA. J.E. Kinsella, S.L. Taylor (Eds.).
73. Rowland I.R., Tanaka R. The effects of transgalactosyled oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J. Appl. Bacteriol. 1993, 74:667-674.
74. Tanaka R., Takayama H., Morotomi M., Kuroshima T., Ueyama S., Matsumoto K., Kuroda A., Mutaim A. Effects of adminstration of TOS and bifidobacterium breve 4006 on the human faecal flora. Bifidobacteria Microflora 1983, 2:17-24.
75. Bouhnik Y., Flourie B., D'Agray-Abensour L., Pochart P., Gramet G., Durand M., Rambaud J.C. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans. J. Nutr. 1997, 127:444-448.
76. Boehm G., Jelinek J., Stahl B., Knol J., Miniello V.L., Moro G.E. Prebiotics carbohydrates in human milk and formulas. Acta Paediatr. 2005, 94:18-21.
77. Hopkins M., Macfarlane G. Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro. Appl. Environ. Microbiol. 2003, 69:1920-1927.
78. Chierici R., Fanaro S., Saccomandi D., Vigi V. Advances in the modulation of the microbial ecology of the gut in early infancy. Acta Paediatr. 2003, 91:56-63.
79. Ito M., Kimura M., Deguchi Y., Miyamori-Watabe A., Yajima T., Kan T. Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism. J. Nutr. Sci. Vitaminol(Tokyo) 1993, 39:279-288.
80. Shoaf K., Mulvey G.L., Armstrong G.D., Hutkins R.W. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun. 2006, 74:6920-6928.
81. Tzortzis G., Goulas A.K., Gee J.M., Gibson G.R. A novel galactooligosaccharide mixture increases the bifidobacterial population in a continuous in vitro fermentation system and in the proximal colonic contents of pigs in vivo. J. Nutr. 2005, 135:1726-1731.
82. Asahara T., Nomoto K., Shimizu K., Watanuki M., Tanaka R. Increased resistance of mice to Salmonella enterica serovar typhimurium infection by synbiotic adminstration of bifidobacteria and transgalactosylated oligosaccharides. J. Appl. Microbiol. 2001, 91:985-996.
83. Rivero M. Effect of a new infant formula enriched with prebiotics, probiotics, nucleotides and LC-PUFAs on infants recovery after an infection. J. Pediatr. Gastroenterol. Hepatol. Nutr. 2004, 9:81-86.
84. Sazawal S., Dhingra U., Sarkar A., Dhingra P., Deb S., Marwah D., Menon V.P., Kumar J., Black R.E. Efficacy of milk fortified with a probiotic Bifidobacterium lactis (DR-10TM) and prebiotic galacto-oligosaccharides in prevention of morbidity and on nutritional status. Asia Pac. J. Clin. Nutr. 2004, 13:28.
85. Carpita N.C., Gibeaut D.M. Structural models of primary cell walls in flowering plants: Consistency of molecular structure with the physical propterties of the walls during growth. Plant J. 1993, 3:1-30.
86. Thakur B.R., Singh R.K., Hand A.K. Chemistry and uses of pectin - A review. Crit. Rev. Food Sci. Nutr. 1997, 37:47-73.
87. Brett C., Waldron K. Physiology and Biochemistry of Plant Cell Walls 1990, 1-57. Unwin Hyman, London.
88. Vidal S., Doco T., Williams P., Pellerin P., York W.S., O'Neill M.A., Glushka J., Darvill A.G., Albersheim P. Structural characterization of the pectic polysaccharide rhamnogalacturonan II: Evidence for the backbone location of the aceric acid-containing oligoglycosyl side chain. Carbohydr. Res. 2000, 326:277-294.
89. Schols H.A., Posthumus M.A., Voragen A.G. J. A xylogalacturonan subunit present in the modified hairy regions of apple pectin. Carbohydr. Res. 1995, 279:265-279.
90. de Vries J.A., Voragen A.G.J., Rombouts F.M., Pilnik W. Distribution of methoxyl groups in apple pectic substances. Carbohydr. Polym. 1983, 3:245-258.
91. Willats W.G.T., McCartney L., Mackie W., Knox J.P. Pectin: Cell biology and prospects for functional analysis. Plant Mol. Biol. 2001, 47:9-27.
92. Oechslin R., Lutz M., Amadò R. Pectic substances isolated from apple cellulosic residue: Structural characterization of a new type of rhamnogalacturonan I. Carbohydr. Polym. 2003, 51:301-310.
93. Thibault J.F., Ralet M.C. Pectins, their origin, structure and functions. Advanced Dietary Fibre Technology 2001, 369-378. Blackwell, Oxford, UK. B.V. McCleary, L. Prosky (Eds.).
94. May C.D. Industrial pectins: Sources, production and applications. Carbohydr. Polym. 1990, 12:79-99.
95. Voragen A.G.J., Pilnik W., Thibault J.F., Axelos M.A.V., Renard C.M.G.C. Pectins. Food Polysaccharides and Their Applications 1995, 287-339. Marcel Dekker, New York. A.M. Stephen (Ed.).
96. Bjerrum K.S. New applications for pectins. Food Tech Europe 1996, 32-34. Mar/Apr.
97. Fernandez M.L. Pectin. Composition, chemistry, physicochemical properties, food applications, and physiological effects. Handbook of Dietary Fiber 2001, 583-601. Marcel Dekker, New York. S. Sungsoo Cho, M.L. Dreher (Eds.).
98. AACC The definition of dietary fiber. Report of the Dietary Fiber Definition Committee to the Board of Directors of the American Association of Cereal Chemists (AAAC). 10 Jan 2001.
99. Salyers A.A. Fiber and the GI microflora. Dietary Fiber in Health and Disease 1995, 423-432. Eagan Press, St. Paul, MN. D. Kritschevsky, C. Bonfield (Eds.).
100. Schneeman B.O. Dietary fibre and gastrointestinal function. Advanced Dietary Fibre Technology 2001, 64-76. Blackwell, Oxford, UK. B.V. McCleary, L. Prosky (Eds.).
101. Scheppach W., Bartram H.P., Richter F. Role of short-chain fatty acids in the prevention of colorectal cancer. Eur. J. Cancer A 1995, 31:1077-1080.
102. Matsuura Y. Pectic acid degrading enzymes from human feces. Agr. Biol. Chem. 1991, 55:885-886.
103. McCarthy R.E., Kotarski S.F., Salyers A.A. Location and characteristics of enzymes involved in the breakdown of polygalacturonic acid by Bacteroides thetaiotaomicron. J. Bacteriol. 1985, 161:493-499.
104. Dongowski G., Lorenz A., Anger H. Degradation of pectins with different degrees of esterification by Bacteroides thetaiotaomicron isolated from human gut flora. Appl. Environ. Microbiol. 2000, 66:1321-1327.
105. Jensen N.S., Canale-Parola E. Bacteroides pectinophilus sp. nov. and Bacteroides galacturonicus sp. nov.: Two pectinolytic bacteria from the human intestinal tract. Appl. Environ. Microbiol. 1986, 52:880-887.
106. Guggenbichler J.P., De Bettignies-Dutz A., Meissner P., Schellmoser S., Jurenitsch J. Acidic oligosaccharides from natural sources block adherence of Escherichia coli on uroepithelial cells. Pharm. Pharmacol. Lett. 1997, 7:35-38.
107. Kastner U., Glasl S., Follrich B., Guggenbichler J.P., Jurenitsch J. Saure Oligosaccharide als Wirkprinzip von wässrigen Zubereitungen aus der Karotte in der Prophylaxe und Therapie von gastrointestinal Infektionen. Wiener Medizinische Wochenzeitschrift 2002, 152:379-381.
108. 29. FEMS Microbiol. Lett. 2002, 218:101-105.
109. Vaisman N., Boehm G., Jelinek J., Stahl B., Coppa A. Pectin hydrolysate is resistant against digestion during small intestinal passage in eleostoma patients. JPGN 2004, 39:486.
110. Mann M.C., Islam T., Dyason J.C., Florio P., Trower C.J., Thomson R.J., von Itzstein M. Unsaturated N-acetyl-d-glucosaminuronic acid glycosides as inhibitors of influenza virus sialidase. Glycoconj. J. 2006, 23:127-133.
111. Vahouny G.V., Khalafi R., Satchithandanadam S., Watkins D.W., Story J.A., Cassidy M.M., Kritchevsky D. Dietary fiber supplementation and fecal bile acids, neutral steroids and divalent cations in rats. J. Nutr. 1987, 117:2009-2015.
112. Demigné C., Levrat M.A., Rémésy C. Effects of feeding fermentable carbohydrates on the cecal concentrations of minerals and their fluxes between the cecum and blood plasma in the rat. J. Nutr. 1989, 119:1625-1630.
113. Gulfi M., Arrigoni E., Amadò R. Influence of structure on in vitro fermentability of commercial pectins and partially hydrolysed pectin preparations. Carbohydr. Polym. 2005, 59:247-255.
114. Gulfi M., Arrigoni E., Amadò R. The chemical characteristics of apple pectin influence its fermentability in vitro. Lebensm-Wiss Technol. 2006, 39:1001-1004.
115. Manderson K., Pinart M., Tuohy K.M., Grace W.E., Hotchkiss A.T., Widmer W., Yadhav M.P., Gibson G.R., Rastall R.A. In vitro determination of prebiotic properties of oligosaccharides derived from an orange juice manufacturing by-product stream. Appl. Environ. Microbiol. 2005, 71:8383-8389.
116. Tateyama I., Hashii K., Hohno I., Hirai K., Suwa Y., Kiso Y. Effect of xylooligosaccharide intake on severe constipation in pregnant women. J. Nutr. Sci. Vitaminol. 2005, 51:445-448.
117. Palframan R.J., Gibson G.R., Rastall R.A. Carbohydrate preferences of Bifidobacterium species isolated from the human gut. Curr. Issues Intest. Microbiol. 2003, 4:71-75.
118. Hsu C.K., Liao J.W., Chung Y.C., Hsieh C.P., Chan Y.C. Xylooligosaccharides and fructooligosaccharides affect the intestinal microbiota and precancerous colonic lesion development in rats. J. Nutr. 2004, 134:1523-1528.
119. Campbell J.M., Fahey G.C., Wolf B.W. Selected indigestible oligosaccharidesn affect large bowel mass, cecal fecal short-chain fatty acids, pH and microflora in rats. J. Nutr. 1997, 127:130-136.
120. Jaskari J., Kontula P., Siitonen A., Jousimies-Somer H., Mattila-Sandholm T., Poutanen K. Oat beta-glucan and xylan hydrolysates as selective substrates for Bifidobacterium and Lactobacillus strains. Appl. Microbiol. Biotechnol. 1998, 49:175-181.
121. Hilz H., de Jong L.E., Kabel M.A., Schols A., Voragen A.G.J.A. comparison of liquid chromatography, capillary electophoresis, and mass spectrometry methods to determine xyloglucan structures in black currants. J. Chromatography A 2006, 1133:275-286.
122. Ghisolfi J., Roberfroid M.B., Rigo J., Moro G., Polanco I. Infant formula supplemented with probiotics or prebiotics: Never, now, or someday?. JPGN 2002, 35:467-468.
123. Savino F., Palumeri E., Castagno E., Cresi F., Dalmasso P., Cavallo F., Oggero R. Reduction of crying episodes owing to infantile colic: A randomized controlled study on the efficacy of a new infant formula. Eur. J. Clin. Nutr. 2006, 33:1-7.
124. Savino F., Maccario S., Castagno E., Cresi F., Cavallo F., Dalmasso P., Fanaro S., Oggero R., Silvestro L. Advances in the management of digestive problems during the first months of life. Acta Paediatr. 2005, 94:120-124.
125. Savino F., Cresi F., Maccario S., Cavallo F., Dalmasso P., Fanaro S., Oggero R., Vigi V., Silvestro L. Minor' feeding problems during the first months of life: Effect of a partially hydrolysed milk formula containing fructo- and galacto-oligosaccharides. Acta Paediatr. Suppl. 2003, 441:86-90.
126. Knol J., Boehm G., Lidestri M., Negretti F., Jelinek J., Agosti M., Stahl B., Marini A., Mosca F. Increase in faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr. 2005, 94:31-33.
127. Edwards C.A., Rumney C., Davies M., Parrett A.M., Dore J., Martin F., Schmitt J., Stahl B., Norin E., Midtvedt T., Rowland I.R., Heavey P., Köhler H., Stocks B., Schroten H. A human flora-associated rat model of the breast-fed infant gut. JPGN 2003, 37:168-177.
128. Moro G., Arslanoglu S., Stahl B., Jelinek J., Wahn U., Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 2006, 91:814-819.
129. Bjorksten B., Sepp E., Julge K., Voor T., Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J. Allergy Clin. Immunol. 2001, 108:516-520.
130. Vos A.P., Haarman M., Buco A., Govers M., Knol J., Garssen J., Stahl B., Boehm G., M'Rabet L. A specific prebiotic oligosaccharide mixture stimulated delayed-type hypersensitivity in a murine influenza vaccination model. Int. Immunopharmacol. 2006, 6:1277-1286.
131. Bakker-Zierikzee A.M., Tol E.A., Kroes H., Alles M.S., Kok F.J., Bindels J.G. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr. Allergy Immunol. 2006, 17:134-140.
132. Scholtens P.A.M.J., Alles M.S., Bindels J.G., van der Linde E.G.M., Tolboom J.J.M., Knol J. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: A randomised controlled clinical trial. JPGN 2006, 42:553-559.
133. Fanaro S., Jelinek J., Stahl B., Boehm G., Kock R., Vigi V. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: Effect on intestinal flora, stool characteristics, and pH. JPGN 2005, 41:186-190.
134. Finke B. Isolierung und Charakterisierung von Oligosacchariden aus humanen und tierischen Milchen 2000, Ph.D. thesis, Univ. Giessen, Shaker Verlag Aachen, Germany.
135. Marx S.P., Winkler S., Hartmeier W. Metablization of beta-(2,6)-linked fructose-oligosaccharides by different bifidobacteria. FEMS Microbiol. Lett. 2000, 182:163-169.
136. Wang X., Gibson G.R. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine. J. Appl. Bacteriol. 1993, 75:373-380.
137. Gibson G.R., Wang X. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture. FEMS Microbiol. Lett. 1994, 118:121-127.
138. McBain A.J., Macfarlane G.T. Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-stage compound continuous culture system. Scand. J. Gastroenterol. (Suppl.) 1997, 222:32-40.
139. de Wiele T.V., Boon N., Possemiers S., Jacobs H., Verstraete W. Prebiotic effects of chicory inulin in the simulator of the human microbial ecosystem. FEMS Microbiol. Ecol. 2004, 51:143-153.
140. Bello F.D., Walter J., Hertel C., Hammes W.P. In vitro study of prebiotic properties of levan-type exopolysaccharides from lactobacilli and non-digestible carbohydrates using denaturing gradient gel electrophoresis. Syst. Appl. Microbiol. 2001, 24:232-237.
141. Probert H.M., Apajalahti J.H., Rautonen N., Stowell J., Gibson G.R. Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Appl. Environ. Microbiol. 2004, 70:4505-4511.
142. Djouzi Z., Andrieux C. Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with human faecal flora. Br. J. Nutr. 1997, 78:313-324.
143. Howard M.D., Gordon D.T., Garleb K.A., Kerley M.S. Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice and rats. J. Nutr. 1995, 125:2604-2609.
144. Swanson K.S., Grieshop C.M., Flickinger E.A., Bauer L.L., Chow J., Wolf B.W., Garleb K.A., Fahey G.C. Fructooligosaccharides and Lactobacillus acidophilus modify gut microbial populations, total tract nutrient digestibilities and fecal protein catabolite concentrations in healthy adult dogs. J. Nutr. 2002, 132:3721-3731.
145. Ten Bruggencatek S.J., Bovee-Oudenhoven I.M., Lettink-Wissink M.L., Van der Meer R. Dietary fructooligosaccharides increase intestinal permeability in rats. J. Nutr. 2005, 135:837-842.
146. Humblot C., Bruneau A., Sutren M., Lhoste E.F., Dore J., Andrieux C., Rabot S. Brussels sprouts, inulin and fermented milk alter the faecal microbiota of human microbiota-associated rats as shown by PCR-temporal temperature gradient gel electrophoresis using universal, Lactobacillus and Bifidobacterium 16S rRNA gene primers. Br. J. Nutr. 2005, 93:677-684.
147. Brunser O., Gotteland M., Cruchet S., Figueroa G., Garrido D., Steenhout P. Effect of a milk formula with prebiotics on the intestinal microbiota of infants after an anitbiotic treatment. Pediatr. Res. 2006, 59:451-456.
148. Bouhnik Y., Vahedi K., Achour L., Attar A., Salfati J., Pochart P., Marteau P., Flourie B., Bornet F., Rambaud J.C. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans. J. Nutr. 1999, 129:113-116.
149. Kleessen B., Sykura B., Zunft H.J., Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am. J. Clin. Nutr. 1997, 65:1397-1402.
150. Mitsuoka T., Hidaka H., Eida T. Effect of fructo-oligosaccharides on intestinal microflora. Nahrung 1987, 31:427-436.
151. VanLoo J., Clune Y., Bennett M., Collins J.K. The SYNCAN project: Goals, set-up, first results and settings of the human intervention study. Br. J. Nutr. 2005, 93:91-98.
152. Lewis S., Burmeister S., Brazier J. Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: A randomized, controlled study. Clin. Gastroenterol. Hepatol. 2005, 3:442-448.
153. Bouhnik Y., Raskine L., Simoneau G., Paineau D., Bornet F. The capacity of short-chain fructo-oligosaccharides to stimulate faecal bifidobacteria: A dose-response relationship study in healthy humans. J. Nutr. 2006, 28:8.
154. Moro G.E.F., Mosca F., Miniello V.L., Fanaro S., Jelinek J., Stahl B., Boehm G. Effects of a new mixture of prebiotics on faecal flora and stools in term infants. Acta Paediatr. Suppl. 2003, 91:77-79.
155. Bakker-Zierikzee A.M., Alles M.S., Knol J., Kok F.J., Tolboom J.J.M., Bindels J.G. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br. J. Nutr. 2005, 94:783-790.
156. Moro G.E., Stahl B., Fanaro S., Jelinek J., Boehm G., Coppa G.V. Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants. Acta Paediatr. 2005, 94:27-30.
157. Knol J., Scholtens P., Kafka C., Steenbakkers J., Groß S., Helm K., Klarczyk M., Schöpfer H., Böckler H., Wells J. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: More like breast-fed infants. JPGN 2005, 40:36-42.
158. Haarman M., Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 2006, 72:2359-2365.
159. Haarman M., Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 2005, 71:2318-2324.
160. Boehm G., Lidestri M., Casetta P., Jelinek J., Negretti F., Stahl B., Marini A. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in pretern infants. Arch. Dis. Child. 2002, 86:0-4.
161. Rinne M.M., Gueimonde M., Kalliomäki M., Hoppu U., Salminen S.J., Isolauri E. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. FEMS Immunol. Med. Microbiol. 2005, 43:59-65.
162. Schmelzle H., Wirth S., Skopnik H., Radke M., Knol J., Böckler H., Brönstrup A., Wells J., Fusch C. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high β-palmitic acid level, and nondigestible oligosaccharies. JPGN 2003, 36:343-351.
163. Oli M.W., Petschow B.W., Buddington R.K. Evaluation of fructooligosaccharide supplementation of oral electrolyte solutions for treatment of diarrhea: Recovery of the intestinal bacteria. Dig. Dis. Sci. 1998, 43:138-147.
164. Gibson G.R., Beatty E.R., Wang X., Cummings J.H. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 1995, 108:975-982.